He then became founding president and CEO of Orexigen Therapeutics in 2003 .
Crowley left Genzyme to ensure that his children would qualify for a drug developed by the company .
Crowley then became founding president and CEO of Orexigen Therapeutics in 2003 .
Crowley left Genzyme to ensure that his children would qualify for a drug developed by the company .